Xiidra Approved; Pending Effective Date

Posted in Latest News on September 14, 2016.

At the August 19, 2016 Board of Optometry meeting, the board voted and approved the use of Xiidra (Lifitegrast ophthalmic solution 5%) for dry eyes. The formulary rule is in the process of being changed to include Lifitegrast ophthalmic solution 5%.

Until the new rule becomes effective, Florida Optometrists are not allowed to prescribe the medication. The board will place a notification on the website advising when the addition to the rule has become effective.



More Latest News

Board Website Re-Design Survey
November 15, 2023

MQA is planning to revamp the board websites. Please take the survey to give us your recommendations by clicking the survey icon below. Survey closing Friday, 2/2/2024 at 4:30 PM ET Continue reading


Announcing the FY 2022-23 Annual Report and Long-Range Plan
November 1, 2023

An annual publication showcasing trends and information about Florida’s health care regulatory landscape. Continue reading